467 related articles for article (PubMed ID: 28714900)
1. A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease.
Dongiovanni P; Valenti L
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28714900
[TBL] [Abstract][Full Text] [Related]
2. Nutritional therapy for nonalcoholic fatty liver disease.
Dongiovanni P; Lanti C; Riso P; Valenti L
J Nutr Biochem; 2016 Mar; 29():1-11. PubMed ID: 26895659
[TBL] [Abstract][Full Text] [Related]
3. Nutrition and Genetics in NAFLD: The Perfect Binomium.
Meroni M; Longo M; Rustichelli A; Dongiovanni P
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340286
[TBL] [Abstract][Full Text] [Related]
4. Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease.
Tallino S; Duffy M; Ralle M; Cortés MP; Latorre M; Burkhead JL
J Nutr Biochem; 2015 Oct; 26(10):996-1006. PubMed ID: 26033743
[TBL] [Abstract][Full Text] [Related]
5. From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis.
Moore JB
Proc Nutr Soc; 2019 Aug; 78(3):290-304. PubMed ID: 30924429
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview.
Marchisello S; Di Pino A; Scicali R; Urbano F; Piro S; Purrello F; Rabuazzo AM
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010049
[TBL] [Abstract][Full Text] [Related]
7. Physiopathology of nonalcoholic fatty liver disease: from diet to nutrigenomics.
Meneghel P; Pinto E; Russo FP
Curr Opin Clin Nutr Metab Care; 2022 Sep; 25(5):329-333. PubMed ID: 35920204
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
Streba LA; Vere CC; Rogoveanu I; Streba CT
World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
[TBL] [Abstract][Full Text] [Related]
9. Role of nutrition, gene polymorphism, and gut microbiota in non-alcoholic fatty liver disease.
Kong L; Lu Y; Zhang S; Nan Y; Qiao L
Discov Med; 2017 Sep; 24(131):95-106. PubMed ID: 28972878
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease.
Panera N; Gnani D; Crudele A; Ceccarelli S; Nobili V; Alisi A
World J Gastroenterol; 2014 Nov; 20(41):15079-86. PubMed ID: 25386056
[TBL] [Abstract][Full Text] [Related]
11. Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease.
Lombardi R; Iuculano F; Pallini G; Fargion S; Fracanzani AL
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228237
[TBL] [Abstract][Full Text] [Related]
12. Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD).
Del Campo JA; Gallego-Durán R; Gallego P; Grande L
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562725
[TBL] [Abstract][Full Text] [Related]
13. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).
Buzzetti E; Pinzani M; Tsochatzis EA
Metabolism; 2016 Aug; 65(8):1038-48. PubMed ID: 26823198
[TBL] [Abstract][Full Text] [Related]
14. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.
Kirpich IA; Marsano LS; McClain CJ
Clin Biochem; 2015 Sep; 48(13-14):923-30. PubMed ID: 26151226
[TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic mechanisms of NASH.
Eslam M; George J
Hepatol Int; 2016 May; 10(3):394-406. PubMed ID: 26683320
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota: Association with NAFLD and Metabolic Disturbances.
Lau E; Carvalho D; Freitas P
Biomed Res Int; 2015; 2015():979515. PubMed ID: 26090468
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease and associated dietary and lifestyle risk factors.
Al-Dayyat HM; Rayyan YM; Tayyem RF
Diabetes Metab Syndr; 2018 Jul; 12(4):569-575. PubMed ID: 29571977
[TBL] [Abstract][Full Text] [Related]
18. Obesity, fatty liver disease and intestinal microbiota.
Arslan N
World J Gastroenterol; 2014 Nov; 20(44):16452-63. PubMed ID: 25469013
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
20. Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD).
Alwahsh SM; Gebhardt R
Arch Toxicol; 2017 Apr; 91(4):1545-1563. PubMed ID: 27995280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
